| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6022396 | Neurobiology of Disease | 2013 | 8 Pages |
Abstract
⺠The D2/3 dopamine agonist Pramipexole possesses reinforcing properties. ⺠Parkinson-like dopaminergic loss does not modify these reinforcing properties. ⺠Both sham and lesioned groups feature high-responders. ⺠Differential vulnerability among patients may underlie side effects of D2/3 agonists.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Michel Engeln, Serge H. Ahmed, Caroline Vouillac, François Tison, Erwan Bezard, Pierre-Olivier Fernagut,